Full-text search

Results for “THC VENTURE II LLC”

Search across the indexed text of every released document.

725 documents found

Cannabis Investment Report | December 2017
document IMAGES-008-HOUSE_OVERSIGHT_024662.txt House Oversight Committee — Epstein Estate Records (Nov 2025)

…et specific health conditions or otherwise cause an intended, desirable effect on users. Cannabis strains with specific THC to CBD ratios are currently the predominant focus for therapeutic applications. THC to CBD ratios in strains popular for treating certain medical conditions...

CAPITAL CHAPTER IV U.S. Legal Landscape
document IMAGES-008-HOUSE_OVERSIGHT_024719.txt House Oversight Committee — Epstein Estate Records (Nov 2025)

…tent 27,475), cannabis cultivation and processing methods (U.S. Patent 9,095,554), a vaporizer (U.S. Patent 9,220,294), THC-infused shea butter for topical application (U.S. Patent 8,425,954), a THC extraction method (U.S. Patent 6,365,416) and equipment and methods for biosynthe...

ITAL Cannabis Investment Report | December 2017
document IMAGES-008-HOUSE_OVERSIGHT_024806.txt House Oversight Committee — Epstein Estate Records (Nov 2025)

… on cannabinoid receptors in cells in the human nervous and immune systems Cannabinol (CBN) a cannabinoid derived from THC degradation; shown to produce some psycho- active effects and believed to have several medicinal benefits, including analgesic, antibacterial, anticonvulsiv...

Cannabis Investment Report | December 2017
document IMAGES-008-HOUSE_OVERSIGHT_024744.txt House Oversight Committee — Epstein Estate Records (Nov 2025)

… states will adopt recreational laws; (4) the FDA will adopt routine approval procedures for drugs with extracts of low-THC/high-CBD cannabis varieties; (5) the FDA will adopt routine approval procedures for drugs with extracts of high-THC cannabis varieties; and (6) cannabis par...

Trinidad, California
document IMAGES-008-HOUSE_OVERSIGHT_024787.txt House Oversight Committee — Epstein Estate Records (Nov 2025)

…he company develops pre-filled cannabis vaporizers, car- tridges and wax that offer the consumer formu- lations of both THC and CBD. The company’s products are available in dispensaries through- out California. © 2017 Ackrell Capital, LLC | Member FINRA/SIPC CHAPTER VIII Top 10...

Cannabis Investment Report | December 2017
document IMAGES-008-HOUSE_OVERSIGHT_024746.txt House Oversight Committee — Epstein Estate Records (Nov 2025)

…edical Cannabis Laws More States Adopt Recreational Laws 15% FDA Routinely Approves CBD Drugs FDA Routinely Approves THC Drugs 10% — Federal Government Legalizes Cannabis 5% - 0% - 2016 «2017 «2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 Source: Ackrell...

Part 2: Filer's Employment Assets and Income
document IMAGES-004-HOUSE_OVERSIGHT_016709.txt House Oversight Committee — Epstein Estate Records (Nov 2025)

Filer’s Name a Donald J. Trump Part 2: Filer's Employment Assets and Income |Description EIF |attached schedule Income Amount | (Part 2 - BIT A) ; Reference # TRUMP TOWER MANAGING MEMBER INC. WA 1445 $1,001 - $15,000 None (or less than $201) Value reported reflects bank accoun...

The Fund Managers have a proactive approach to deal sourcing, which focuses on both private
document IMAGES-007-HOUSE_OVERSIGHT_024054.txt House Oversight Committee — Epstein Estate Records (Nov 2025)

…ivate and public opportunities. The established and proven sourcing activities seek to identify the most compelling healthcare technology investment opportunities, at the most attractive time points for venture capital investment. The Fund Managers’ goal is to identify opportunit...

Report on Stem Cells future
email TEXT-001-HOUSE_OVERSIGHT_013482.txt Nov 22, 2012 House Oversight Committee — Epstein Estate Records (Nov 2025)

From: Steven Victor MD 111.11111..... Sent: 11/23/2012 1:06:38 PM To: CC: Subject: Report on Stem Cells future PUBLISHED: 22 NOVEMBER 2012 The view from the US: Stem cell therapy steps up a gear with first approval and improved political climate Special Report Peter Winter Positi...

molecular immunology at The Pasteur Institute and earned an M.D. and Ph.D. from the
document IMAGES-007-HOUSE_OVERSIGHT_024023.txt House Oversight Committee — Epstein Estate Records (Nov 2025)

… (acquired by Abbott), PercuSurge (acquired by Medtronic), and NxStage Medical (NASDAQ: NXTM). Prior to joining the healthcare investment team at Sprout, Jeani was a General Partner at Weiss, Peck & Greer Venture Partners (“WPGVP”) where she focused on healthcare investments. Bef...

number of commercial stage companies with novel and clearly differentiated products targeting
document IMAGES-007-HOUSE_OVERSIGHT_024020.txt House Oversight Committee — Epstein Estate Records (Nov 2025)

…e networks of deal sources that have been built and cultivated over two decades and focus on identifying compelling healthcare technology investment opportunities, at attractive time points for investment. These efforts balance the inherent attractiveness of an innovative technol...

James Niedel, MD, Ph.D., (70), Venture Partner, joined Sprout in May 2002 and helped found
document IMAGES-007-HOUSE_OVERSIGHT_024024.txt House Oversight Committee — Epstein Estate Records (Nov 2025)

James Niedel, MD, Ph.D., (70), Venture Partner, joined Sprout in May 2002 and helped found New Leaf in 2005. Jim will change his status to Venture Partner in NLV-II] with the closing of the new fund. In this role, Jim will work full-time as a senior member of the NLV investment t...

NLV-I has capital commitments of $310 million, and the Fund Managers began investing in
document IMAGES-007-HOUSE_OVERSIGHT_024030.txt House Oversight Committee — Epstein Estate Records (Nov 2025)

… CVRs on three realized investments. NLV-I is in the top quartile of funds tracked by Cambridge Associates for U.S. healthcare venture capital in the 2005 vintage year. NLV-II has capital commitments of $450 million, and the Fund Managers began investing in 2008. The fund will c...